NCT02732496

Brief Summary

The investigators will conduct a randomized placebo-controlled trial of a computerized intervention targeting working memory in 30 children with comorbid Attention-Deficit/Hyperactivity Disorder (ADHD) and Tourette Syndrome (TS).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 8, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2017

Completed
Last Updated

August 3, 2018

Status Verified

August 1, 2018

Enrollment Period

1.4 years

First QC Date

March 3, 2016

Last Update Submit

August 2, 2018

Conditions

Keywords

Attention-Deficit/Hyperactivity DisorderTourette SyndromeWorking Memory Training

Outcome Measures

Primary Outcomes (4)

  • Spatial Working Memory (SWM) subtest from the Cambridge Neuropsychological Test Automated Battery (CANTAB)

    The SWM subtest assesses working memory.

    3 months

  • Spatial Span (SSP) subtest from the Cambridge Neuropsychological Test Automated Battery (CANTAB)

    The SSP subtest assesses working memory.

    3 months

  • The Working Memory Index from the Behavior Rating Inventory of Executive Function (BRIEF)

    Parent and teacher ratings on the Working Memory Index of the BRIEF assess working memory.

    3 months

  • The Behavioral Regulation Index from the Behavior Rating Inventory of Executive Function (BRIEF)

    Parent and teacher ratings on the Behavioral Regulation Index of the BRIEF assess working memory.

    3 months

Study Arms (2)

Cognitive Training

EXPERIMENTAL

Targeted Cognitive Training (TCT)

Behavioral: Targeted Cognitive Training (TCT)

Youth Appropriate Online Games

PLACEBO COMPARATOR

Engaging games not designed to improve cognition

Other: Youth Appropriate Online Games

Interventions

The instructors have selected a set of computer exercises designed to specifically target working memory, which is a cognitive construct relevant to ADHD and Tourette Syndrome. The tasks were designed to benefit subjects through principles of learning-dependent plasticity.

Cognitive Training

Engaging games not designed to improve cognition.

Youth Appropriate Online Games

Eligibility Criteria

Age7 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The investigators will include youth who have undergone neuropsychological testing in the prior 3 years.

You may not qualify if:

  • The investigators will exclude patients with intellectual disability in order to more directly extend the prior literature to the ADHD+TS population.
  • The investigators will exclude patients with severe tics as evidenced by a score of \> 30 on the clinician administered Yale Global Tic Severity Scale (YGTSS).
  • The investigators will exclude patients with moderate to severe Obsessive Compulsive Disorder (OCD) symptoms, as evidenced by a score of \>30 on the clinician administered Children's Yale-Brown Obsessive Compulsive Scale (CYBOCS).
  • The investigators will exclude patients treated with neuroleptics, given that these medications can be cognitively dulling and sedating and potentially lead to secondary working memory impairments.
  • The investigators will exclude families who do not have a computer with an internet connection in their homes, and in which neither a parent nor the child has an email address to receive study related communications.
  • The investigators will exclude families who anticipate or are likely to have a change in therapeutic treatments (i.e., psychotherapy or psychopharmacology) during the time frame of the trial.
  • NOTE: Patients treated with ADHD medications will not be excluded, but medications will be recorded for covariate analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivityTourette Syndrome

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • M. Zelime Elibol, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor in Neurology, Harvard Medical School

Study Record Dates

First Submitted

March 3, 2016

First Posted

April 8, 2016

Study Start

June 1, 2016

Primary Completion

November 3, 2017

Study Completion

November 3, 2017

Last Updated

August 3, 2018

Record last verified: 2018-08